Credit Morning 06/24/2025

Webuild: New HY issuance and tender offer|Skechers has announced plans to issue debt in euros and dollars|

Morning Crédit 24/06/2025

Webuild: New HY issuance and tender offer|Skechers : projet d’émission obligataire|

Grifols S.A.: 1 director

A director at Grifols S.A. bought 735,923 shares at 10.520EUR and the significance rating of the trade was 100/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clearl...

GSK: 1 director

A director at GSK sold 29,763 shares at 1,544p and the significance rating of the trade was 91/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clearly showing Close ...

Morning Crédit 12/06/2025

Fnac Darty – Investor Day : plan de renforcement des marges et des cash-flows avec maintien d’un levier bas|TDF : les actionnaires auraient choisi des banques pour diriger une possible vente|Clariane va céder son réseau Petits-fils à Crédit Agricole Santé & Territoires pour 345 m EUR|Déclarations d’Andrea Orcel sur Commerzbank et BPM|

Credit Morning 06/12/2025

Fnac Darty – Investor Day: a plan to strengthen margins and cash flows while maintaining a low leverage target|TDF: shareholders have reportedly chosen banks to manage a potential sale (Bloomberg)|Clariane is selling its Petits-fils network to Crédit Agricole Santé & Territoires for €345m.|Andrea Orcel's statements on Commerzbank and BPM|

Morning Crédit 23/05/2025

Carrefour et Ahold Delhaize aurait envisagé un rapprochement, sans succès|Grifols : Moody’s relève le rating corporate de B3/positive à B2/positive|

Credit Morning 05/23/2025

Carrefour and Ahold Delhaize reportedly considered a merger, without success|Grifols: Moody’s raises the corporate rating from B3/positive to B2/positive|

INVEST SECURITIES - GRIFOLS : L'immunoglobuline mène la danse, objecti...

Credit Morning 05/13/2025

Cellnex issues € 750m of new 2032 notes|Grifols : Q1 2025 earnings above expectations, FY guidance maintained despite weaker US dollar|90-day truce in the trade war between the United States and China|

ODDO BHF SECURITIES LARGE CAPS MORNING NEWS 05/13/2025

ODDO BHF SECURITIES LARGE CAPS MORNING NEWS 13/05/2025

Morning Crédit 13/05/2025

Cellnex émet 750 m EUR de nouvelles obligations 2032|Grifols : résultats supérieurs aux attentes au T1 2025, guidance annuelle confirmée malgré la dépréciation du dollar US|Trêve de 90 jours dans la guerre commerciale entre les Etats-Unis et la Chine|

Grifols A : Q1 operating numbers broadly in line, earnings above, guid...

MFN Drug Pricing - Impact and Implementation (Thematic, 5pgs)

Ahead of today’s signing of an Executive Order to introduce a Most Favoured Nation approach to drug pricing in the US, we show that net pricing in the EU is c.50% lower than in the US & which companies have most to lose from MFN. We also show that, in reality,

Credit Morning 05/07/2025

CVC Capital Partners is considering a bid for Avolta (Sky News)|Coty : new profit warning|Golden Goose is preparing a € 480m senior secured FRN issue|AccorInvest : Plan for a €1.25 bn bond issue and new syndicated loan|BPCE delivers strong Q1 2025 results|

Morning Crédit 07/05/2025

CVC Capital Partners étudierait une offre d’achat sur Avolta (Sky News)|Coty : nouveau profit warning à l’issue du T3|Golden Goose prépare une émission obligataire FRN de 480 m EUR|AccorInvest : Projet d’un placement obligataire de 1.25 md EUR et mise en place d’un nouveau crédit syndiqué|BPCE délivre de solides résultats T1 2025|

US Tariffs - Broad Tariffs are Highly Unlikely (7pgs)

Following a number of recent events, we discuss in this note what we think is the most likely outcome for the Pharma industry. We show that broad based tariffs on drugs are highly unlikely, that even if it were to happen, the impact of a 20% tariff is

Credit Morning 04/15/2025

Automotive: Trump raises possibility of reprieve on automotive tariffs|LVMH: disappointing Q1 sales|Bayer says glyphosate production could end|

Morning Crédit 15/04/2025

Automobile : Trump évoque un possible sursis sur les droits de douane automobiles|LVMH : déception sur les ventes T1|Bayer says glyphosate production could end|